These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1827433)

  • 1. Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study.
    Brown TD; Goodman PJ; Fleming TR; Baker LH; Macdonald JS
    Invest New Drugs; 1991 Feb; 9(1):77-8. PubMed ID: 1827433
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II study of intravenous menogaril in advanced ovarian carcinoma. EORTC Early Clinical Trials Group.
    Sessa C; Kaye SB; Renard J; ten Bokkel Huinink W; Cavalli F
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):751-2. PubMed ID: 2523809
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
    Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of menogaril (NSC-269148) in non-small cell lung carcinoma. A Southwest Oncology Group study.
    Vance RB; Crowley JJ; Macdonald JS; Ahmann FR
    Invest New Drugs; 1991 Feb; 9(1):73-5. PubMed ID: 1851143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of menogaril in advanced colorectal cancer.
    Holdener EE; ten Bokkel Huinink WW; Decoster G; Ludwig C; Renard G; Pinedo HM
    Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas.
    Sternberg CN; Magill GB; Cheng EW; Hollander P
    Am J Clin Oncol; 1988 Apr; 11(2):174-6. PubMed ID: 2965856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
    Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
    Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
    [No Abstract]   [Full Text] [Related]  

  • 8. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
    Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J
    Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of intravenous menogaril in patients with advanced breast cancer.
    Sessa C; Gundersen S; ten Bokkel Huinink W; Renard J; Cavalli F
    J Natl Cancer Inst; 1988 Sep; 80(13):1066-9. PubMed ID: 2970554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study of menogaril in low-grade non-Hodgkin's lymphoma. An NCI Canada Clinical Trials Group study.
    Skillings J; Cripps C; Eisenhauer E; Pater J; Verma S; Walde D
    Invest New Drugs; 1991 Feb; 9(1):79-82. PubMed ID: 1827434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II study of oral menogaril as first line chemotherapy for advanced breast cancer: a National Cancer Institute of Canada Clinical Trials Group study.
    Stewart DJ; Eisenhauer EA; Skillings J; Pritchard KI; Buckman R; VAndenberg T; Verma S; Aitken S; Norris B
    Ann Oncol; 1992 Mar; 3(3):201-4. PubMed ID: 1534021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of menogaril in patients with advanced hypernephroma.
    Long HJ; Hauge MD; Therneau TM; Buckner JC; Frytak S; Hahn RG
    Invest New Drugs; 1991 Aug; 9(3):261-2. PubMed ID: 1838363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menogaril in the treatment of relapsed multiple myeloma. A phase II trial of the Cancer Center of Wake Forest University.
    Cruz JM; Case LD; Dalton HB; Ramseur WL; Richards F; Jackson DV; Muss HB; Zekan PJ; Brodkin RA; Brown RC
    Invest New Drugs; 1992 Apr; 10(1):35-7. PubMed ID: 1535064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer.
    Kennedy MJ; Donehower RC; Grochow LB; Ettinger DS; Fetting JH; Abeloff MD
    Invest New Drugs; 1990 Aug; 8(3):289-94. PubMed ID: 2148742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I study of menogaril in patients with advanced cancer.
    Brown TD; Donehower RC; Grochow LB; Rice AP; Ettinger DS
    J Clin Oncol; 1987 Jan; 5(1):92-9. PubMed ID: 2949065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of oral menogaril administered daily for 14 consecutive days.
    Stewart DJ; Aitken SE; Verma S; Maroun JA; Robillard L; Touchie M; Prosser IA; Earhart R
    Ann Oncol; 1992 May; 3(5):401-3. PubMed ID: 1535508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of oral menogaril administered on a once weekly schedule.
    Stewart DJ; Verma S; Maroun JA; Robillard L; Earhart RH
    Invest New Drugs; 1990 Feb; 8(1):43-52. PubMed ID: 2140564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
    Stephens RL; Goodman P; Crawford ED; Spicer CF; Lowe BA; Ahmann FR; Chapman R; Natale RB
    Invest New Drugs; 1990; 8 Suppl 1():S69-71. PubMed ID: 2143177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II evaluation of menogaril in cisplatin-refractory advanced ovarian carcinoma. A collaborative trial of the North Central Cancer Treatment Group and the Mayo Clinic.
    Long HJ; Laurie JA; Wieand HS; Edmonson JH; Levitt R; Krook JE; Abu-Ghazaleh S
    Cancer; 1991 Aug; 68(4):730-2. PubMed ID: 1830238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.